Pharmaceuticals Italy

Italy Malaria Vaccines Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

Italy Malaria Vaccines Market Industry Trends and Forecast to 2034: Segmented by (Product, Region, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Italy · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $5.2 Mn Placeholder estimate
Estimate 2025 $6.5 Mn 2.1% of the global market
Projected 2034 $45.6 Mn 603.2% Adds $39.1 Mn over 9 forecast years
CAGR 2025–2034 24.2% Faster than 92% of 180 Pharmaceuticals markets here
Key players 5
  • Italy is 2.07% of the global market.
  • In Europe, the largest is Germany at $11.0 Mn.
  • Fastest growing: Russia at 24.9% a year.
  • Italy ranks 4th of 6 by size in Europe.

Market size projection

Italy

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$39.1 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Malaria Vaccines Market market size by year, Italy
YearMarket sizeChange that yearSince 2025
2024 (estimate) $5.2 Mn — —
2025 (base) $6.5 Mn +$1.3 Mn —
2026 (forecast) $8.0 Mn +$1.6 Mn +24.2%
2027 (forecast) $10.0 Mn +$1.9 Mn +54.3%
2028 (forecast) $12.4 Mn +$2.4 Mn +91.6%
2029 (forecast) $15.4 Mn +$3.0 Mn +138%
2030 (forecast) $19.1 Mn +$3.7 Mn +195.5%
2031 (forecast) $23.8 Mn +$4.6 Mn +267.1%
2032 (forecast) $29.5 Mn +$5.8 Mn +355.9%
2033 (forecast) $36.7 Mn +$7.1 Mn +466.2%
2034 (forecast) $45.6 Mn +$8.9 Mn +603.2%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $312.5 Mn
  2. North America $166.5 Mn
  3. US $114.6 Mn
  4. APAC $75.7 Mn
  5. Europe $62.7 Mn
  6. Canada $26.0 Mn
  7. China $22.5 Mn
  8. Japan $21.0 Mn
  9. Latin America $12.5 Mn
  10. Middle East $12.5 Mn
  11. Germany $11.0 Mn
  12. UK $7.7 Mn
  13. Brazil $7.8 Mn
  14. France $7.4 Mn
  15. Italy (this report) $6.5 Mn
  16. Spain $6.1 Mn
  17. Ecuador $5.8 Mn
  18. India $5.7 Mn
  19. Africa $5.4 Mn
  20. Saudi Arabia $5.0 Mn
  21. Mexico $4.7 Mn
  22. Australia $3.9 Mn
  23. New Zealand $3.6 Mn
  24. Russia $3.3 Mn
  25. South Africa $2.2 Mn
  26. UAE $1.7 Mn
  27. Egypt $1.0 Mn
  28. Philippines $0.8 Mn
  29. Hong Kong $0.5 Mn
  30. Malaysia $0.5 Mn
  31. Singapore $0.5 Mn
  32. Thailand $0.3 Mn
  33. Kenya $0.2 Mn

Report snapshot

Italy Malaria Vaccines Market Analysis at a glance
Market size, 2025$6.5 Mn placeholder estimate
Forecast, 2034$45.6 Mn placeholder estimate
Growth (CAGR), 2025–203424.2% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsProduct, region and end user (see all)
Key playersGSK PLC, Serum Institute of India, Bharat Biotech, Sanaria, BioNTech (see all)
Regulator in ItalyAIFASource: Italian Medicines Agency (AIFA). Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Italy Malaria Vaccines Market Analysis Executive Summary

Malaria vaccines protect young children in high-risk areas against malaria, a leading cause of child deaths in Africa.

Key segments of the malaria Vaccines market include product (RTS,S/AS01, R21/Matrix-M and Candidates) and region (Sub-Saharan Africa, Asia and Latin America).

Bar chart: Italy Malaria Vaccines market size, 2024–2034, placeholder estimates. $5.2 Mn in 2024, $6.5 Mn in 2025 and $45.6 Mn in 2034, 24.2% CAGR.
Italy Malaria Vaccines market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Italy Malaria Vaccines Market Dynamics

Market Growth Drivers

Rising antimicrobial resistance, outbreaks of new and returning diseases, climate change spreading infections and strong global funding for prevention are driving the malaria Vaccines market.

Opportunity

New vaccines, rapid tests and public-private funding for neglected diseases give the malaria Vaccines market room to grow, especially in Asia, Africa and Latin America.

Market Restraints

Low prices in poorer markets, weak returns for new antibiotics, vaccine hesitancy and cold-chain problems hold back the malaria Vaccines market.

Competitive Landscape for Malaria Vaccines Market in Italy

The malaria Vaccines market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Malaria Vaccines Market in Italy

Malaria Vaccines in Italy: rules and payment

Medicines are authorised either for the whole EU by the European Commission, after review by the European Medicines Agency (EMA), or nationally by AIFA, the Italian Medicines Agency, which also negotiates prices and reimbursement.⁠[1] The National Health Service (SSN), run by the regions, gives universal cover, and AIFA decides which medicines it pays for.⁠[2]

[1] Italian Medicines Agency (AIFA). Checked 14 Nov 2026.

[2] Italian Ministry of Health. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for malaria Vaccines. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in Italy.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Malaria Vaccines right now, from free public sources.

Latest research 325 papers since 2021 (worldwide)

  1. New sites of vulnerability to stop vivax malaria. Trends in parasitology, 2026
  2. First-in-human trial in Burkinabe adults and children of replication-competent, genetically attenuated PfSPZ-LARC2 Vaccine for malaria. medRxiv : the preprint server for health sciences, 2026
  3. Economic Evaluations for Malaria Vaccines: A Systematic Review. Value in health regional issues, 2026
  4. Preclinical Evaluation of the SMNP-Adjuvanted R21 Malaria Vaccine Across Multiple Mouse Strains. Vaccines, 2026
  5. Transgenic Plasmodium berghei expressing P. vivax pre-erythrocytic antigens SSP3 and SPECT1 to elucidate their efficacy towards vaccine development. PLoS neglected tropical diseases, 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Malaria Vaccines in context

Italy compared

  • Health spending per person: 3,398 US$ per person (2024). World: 1,317 US$ per person (2023). 4th highest of the 6 countries we cover in Europe.[1]
  • Doctors: 4.19 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). 4th highest of the 6 countries we cover in Europe.[2]
  • People aged 65 and over: 25.1% of people (2025). World: 10.4% of people (2025). Highest of the 6 countries we cover in Europe.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 15 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Malaria Vaccines market in Italy?
Placeholder estimate: about $6.5 Mn in 2025, rising to about $45.6 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Malaria Vaccines market in Italy growing?
Placeholder estimate: about 24.2% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Malaria Vaccines market report cover?
The report splits the market by product (RTS,S/AS01, R21/Matrix-M, Candidates), region (Sub-Saharan Africa, Asia, Latin America) and end user (Hospitals, Specialty Clinics, Retail Pharmacies, Online Pharmacies).
Who are the key players in the Malaria Vaccines market?
Key players include GSK PLC, Serum Institute of India, Bharat Biotech, Sanaria and BioNTech.
What is driving the Malaria Vaccines market?
Rising antimicrobial resistance, outbreaks of new and returning diseases, climate change spreading infections and strong global funding for prevention are driving the malaria Vaccines market.
Who regulates Malaria Vaccines in Italy?
Medicines are authorised either for the whole EU by the European Commission, after review by the European Medicines Agency (EMA), or nationally by AIFA, the Italian Medicines Agency, which also negotiates prices and reimbursement. Source: Italian Medicines Agency (AIFA). Checked 14 Nov 2026.
How is healthcare paid for in Italy?
The National Health Service (SSN), run by the regions, gives universal cover, and AIFA decides which medicines it pays for. Source: Italian Ministry of Health. Checked 14 Nov 2026.
How much research is published on Malaria Vaccines?
PubMed lists 325 papers on Malaria Vaccines added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about Malaria Vaccines in Italy? Our analysts can size it for your plan. Talk to us See the public data Measles vaccine for every country, free. Open the Public Health Dashboard

From our blog

Biologic Safety Testing: The Quiet Backbone of Drug MakingEvery vaccine, antibody and cell therapy must be tested for sterility, purity and viruses before it reaches…
Back to Catalogue
Keep exploring

Related Pharmaceuticals reports in Italy

See all
Same topic, other categories

Related on vaccines and malaria

See the topic